Literature DB >> 20476805

Long double-stranded RNA produces specific gene downregulation in Giardia lamblia.

Maria R Rivero1, Liudmila Kulakova, Maria C Touz.   

Abstract

In many eukaryotes, the introduction of double-stranded RNA (dsRNA) into cells triggers the degradation of mRNAs through a post-transcriptional gene-silencing mechanism called RNA interference or RNAi. In the present study, we found that endogenous long-dsRNA was substantially more effective at producing interference than endogenous, or exogenous, short-dsRNA expression in Giardia lamblia . The effects of this interference were not evident in the highly expressed protein tubulin or the stage-specific cyst wall protein 2. However, long-dsRNA caused potent and specific interference in the medium subunits of adaptins, the RNA-dependent RNA polymerase, and the exogenous green fluorescence protein. Our results suggest that the ability of dsRNA antisense to inhibit the expression of these specific types of proteins is indicative of a gene-specific mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20476805      PMCID: PMC2924914          DOI: 10.1645/GE-2406.1

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  21 in total

1.  Variant-specific surface protein switching in Giardia lamblia.

Authors:  T E Nash; H T Luján; M R Mowatt; J T Conrad
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Detailed characterization of the posttranscriptional gene-silencing-related small RNA in a GUS gene-silenced tobacco.

Authors:  G Hutvágner; L Mlynárová; J P Nap
Journal:  RNA       Date:  2000-10       Impact factor: 4.942

Review 3.  Antisense RNA and RNAi in protozoan parasites: working hard or hardly working?

Authors:  Kevin T Militello; Philippe Refour; Christy A Comeaux; Manoj T Duraisingh
Journal:  Mol Biochem Parasitol       Date:  2007-10-18       Impact factor: 1.759

4.  Structural basis for double-stranded RNA processing by Dicer.

Authors:  Ian J Macrae; Kaihong Zhou; Fei Li; Adrian Repic; Angela N Brooks; W Zacheus Cande; Paul D Adams; Jennifer A Doudna
Journal:  Science       Date:  2006-01-13       Impact factor: 47.728

5.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

6.  Inhibition of pyruvate-ferredoxin oxidoreductase gene expression in Giardia lamblia by a virus-mediated hammerhead ribozyme.

Authors:  M Dan; A L Wang; C C Wang
Journal:  Mol Microbiol       Date:  2000-04       Impact factor: 3.501

7.  Double-stranded RNA interference in Trypanosoma brucei using head-to-head promoters.

Authors:  D J LaCount; S Bruse; K L Hill; J E Donelson
Journal:  Mol Biochem Parasitol       Date:  2000-11       Impact factor: 1.759

8.  Silencing genes by RNA interference in the protozoan parasite Entamoeba histolytica.

Authors:  Carlos F Solis; Nancy Guillén
Journal:  Methods Mol Biol       Date:  2008

9.  Identification and characterization of a novel secretory granule calcium-binding protein from the early branching eukaryote Giardia lamblia.

Authors:  María C Touz; Natalia Gottig; Theodore E Nash; Hugo D Lujan
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

10.  snoRNA, a novel precursor of microRNA in Giardia lamblia.

Authors:  Ashesh A Saraiya; Ching C Wang
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

View more
  11 in total

Review 1.  The emerging world of small silencing RNAs in protozoan parasites.

Authors:  Vanessa D Atayde; Christian Tschudi; Elisabetta Ullu
Journal:  Trends Parasitol       Date:  2011-04-15

Review 2.  RNA interference in protozoan parasites: achievements and challenges.

Authors:  Nikolay G Kolev; Christian Tschudi; Elisabetta Ullu
Journal:  Eukaryot Cell       Date:  2011-07-15

3.  A microRNA derived from an apparent canonical biogenesis pathway regulates variant surface protein gene expression in Giardia lamblia.

Authors:  Ashesh A Saraiya; Wei Li; Ching C Wang
Journal:  RNA       Date:  2011-10-27       Impact factor: 4.942

4.  Giardia lamblia transcriptome analysis using TSS-Seq and RNA-Seq.

Authors:  Mohammed E M Tolba; Seiki Kobayashi; Mihoko Imada; Yutaka Suzuki; Sumio Sugano
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

5.  Gene regulation in Giardia lambia involves a putative microRNA derived from a small nucleolar RNA.

Authors:  Wei Li; Ashesh A Saraiya; Ching C Wang
Journal:  PLoS Negl Trop Dis       Date:  2011-10-18

6.  Characterizing ncRNAs in Human Pathogenic Protists Using High-Throughput Sequencing Technology.

Authors:  Lesley Joan Collins
Journal:  Front Genet       Date:  2011-12-27       Impact factor: 4.599

7.  Cyst-Wall-Protein-1 is fundamental for Golgi-like organelle neogenesis and cyst-wall biosynthesis in Giardia lamblia.

Authors:  Jacqueline A Ebneter; Sally D Heusser; Elisabeth M Schraner; Adrian B Hehl; Carmen Faso
Journal:  Nat Commun       Date:  2016-12-15       Impact factor: 14.919

8.  RNAi-Mediated Specific Gene Silencing as a Tool for the Discovery of New Drug Targets in Giardia lamblia; Evaluation Using the NADH Oxidase Gene.

Authors:  Jaime Marcial-Quino; Saúl Gómez-Manzo; Francisco Fierro; Yadira Rufino-González; Daniel Ortega-Cuellar; Edgar Sierra-Palacios; America Vanoye-Carlo; Abigail González-Valdez; Angélica Torres-Arroyo; Jesús Oria-Hernández; Horacio Reyes-Vivas
Journal:  Genes (Basel)       Date:  2017-11-03       Impact factor: 4.096

9.  Resistance formation to nitro drugs in Giardia lamblia: No common markers identified by comparative proteomics.

Authors:  Joachim Müller; Sophie Braga; Manfred Heller; Norbert Müller
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-03-15       Impact factor: 4.077

10.  Robust and stable transcriptional repression in Giardia using CRISPRi.

Authors:  S G McInally; K D Hagen; C Nosala; J Williams; K Nguyen; J Booker; K Jones; Scott C Dawson
Journal:  Mol Biol Cell       Date:  2018-10-31       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.